NP31518 Albumin Products · UK public procurement notice

Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)

Goods

Sectors: Medical Devices & Pharma (33) Delivery: Scotland (UKM)

Awarded value£7,997,002published contract · exc. VAT

Awarded 31 Oct 2018

Awarded to BIO PRODUCTS LABORATORY LIMITED +3 more

What is being bought

Published requirement description

No description was published on the notice. See the official documents.

CPV: Blood products · Plasma extracts

The lotProcurement structure

single lot · no lot value published

Lot #1This modification, effecting an extension of the Framework Agreement duration from…

This modification, effecting an extension of the Framework Agreement duration from 01/03/2023 until 30/04/2023, is necessary to meet the additional demands of the Scottish Health and Social Care sector to maintain necessary supply due to circumstances unforeseen by the Authority pertaining to the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.

Delivery: Scotland · All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

33141510 Blood products 33141520 Plasma extracts

Procedure terms & legal framework

From the official record · publisher note attached

Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Competitive procedure
GPA / WTO covered: Unspecified in notice
Recurring procurement: Unspecified in notice
First published: 12 Jan 2023, 10:15 GMT
Last source update: 12 Jan 2023, 10:15 GMT
FTS notice number: 2023/S 000-000915
Classification (CPV): Blood productsPlasma extracts
Delivery area: Scotland (UKM)
Official registry OCID: ocds-h6vhtk-0396cc Find a Tender

Review and risk notes

Review procedure: Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts: An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has be entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.

Publisher note: The estimated value of the Framework Agreement referred to in Section V.2.4 (comprising two (2) Lots) covers the twenty-six (26) months' initial duration and the twenty-two (22) months' extension duration of the Framework Agreement. (SC Ref:718079)

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £7,997,0021 contract exc. VAT

Contracts signed 1latest 31 Oct 2018

Awarded to	Value	Date	Status
BIO PRODUCTS LABORATORY LIMITED, CSL BEHRING UK LIMITED, Grifols UK, Octapharma Limitedjoint award	£7,997,002 †	—	Awarded

Contracts

NP31518 Albumin Products · BIO PRODUCTS LABORATORY LIMITED, CSL BEHRING UK LIMITED, Grifols UK, Octapharma Limited
Signed
31 Oct 2018
Value
£7,997,002
Status
active
- Change This modification effects an extension of the Framework Agreement duration from 01/03/2023 until 30/04/2023. The modification notice is advised at Framework Agreement level only and so it does not detail individual Lots., Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: This modification is necessary to meet the additional demands of the Scottish Health and Social Care sector to maintain necessary supply due to circumstances unforeseen by the Authority pertaining to the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.

Contracting authority & participating public bodies

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

Contracting authorityNHS & healthcare Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, Scotland, EH12 9EBContact name, email, phone

Dispute resolution & review bodies

Sheriff Court HouseReview body EdinburghContact email

Bidders & participating suppliers

4 commercial parties on the notice

Bio Products LaboratoryAwarded supplier Dagger Lane, Elstree, Hertfordshire, UK, WD6 3BXContact phone
CSL BehringAwarded supplier 4 Milton road, Haywards Heath, South East, RH16 1AHContact phone
Grifols UK LtdAwarded supplier Byron House, Cambridge Business Park, Cambridge, East of England, CB4 0WZContact phone
Octapharma LtdAwarded supplier The Zenith Building, 26 Spring Gardens, Manchester, UK, M2 1ABContact phone

Official documents & specifications

Official links; attachments are not copied

No document links were published on the notice.